Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

Both estrogens and androgens are important for health in both males and females.

Gene variation affects prostate issues and hair loss.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Mutations in certain receptors can cause diseases and offer new treatment options.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

CEC levels may be a useful marker for predicting prostate cancer progression.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Androgens increase cervical cancer risk and affect its development.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.